Z
5.17
-0.23 (-4.29%)
| Previous Close | 5.40 |
| Open | 5.33 |
| Volume | 204,038 |
| Avg. Volume (3M) | 200,941 |
| Market Cap | 244,947,200 |
| Price / Earnings (TTM) | 86.14 |
| Price / Sales | 9.74 |
| Price / Book | 6.59 |
| 52 Weeks Range |
| Profit Margin | 10.69% |
| Operating Margin (TTM) | 15.70% |
| Diluted EPS (TTM) | 0.060 |
| Quarterly Revenue Growth (YOY) | -18.70% |
| Quarterly Earnings Growth (YOY) | -55.30% |
| Total Debt/Equity (MRQ) | 24.98% |
| Current Ratio (MRQ) | 1.38 |
| Operating Cash Flow (TTM) | 54.93 M |
| Levered Free Cash Flow (TTM) | -21.93 M |
| Return on Assets (TTM) | 3.82% |
| Return on Equity (TTM) | 7.15% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Mixed |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Mixed | |
| Stock | Zhengye Biotechnology Holding L | - | - |
AIStockmoo Score
1.0
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 1.0 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | 2.0 |
| Average | 1.00 |
|
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs and is available in 29 provincial regions across China and are exported overseas to Vietnam, Pakistan and Egypt. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| % Held by Insiders | 91.64% |
| % Held by Institutions | 0.01% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 14 Jan 2025 | Announcement | Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters’ Over-Allotment Option |
| 08 Jan 2025 | Announcement | Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering |
| 06 Jan 2025 | Announcement | Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |